Laboratory practicals and data-interpretation exam questions often give two concentration-response curves and ask you to compare potency and efficacy. The values below are invented laboratory data for an isolated-tissue experiment, not doses for patients.
Data. Agonist A produces a maximum response (Emax) of 100% with an EC50 of 10 nM. Agonist B produces a maximum response of only 60% with an EC50 of 100 nM. Both curves have a Hill slope of 1.
Step 1: compare potency using EC50. Potency is about the concentration needed, not the size of the effect. The ratio of EC50 values is 100 nM ÷ 10 nM = 10, so A is 10 times more potent than B. Expressed as pEC50 (the negative log of the EC50 in molar units), A has a pEC50 of 8 and B a pEC50 of 7.
Step 2: compare efficacy using Emax. B reaches only 60% of the system maximum, so B is a partial agonist and A behaves as a full agonist in this tissue. Relative efficacy, expressed as Emax(B) ÷ Emax(A), is 0.6.
Step 3: predict a response. With a Hill slope of 1, response = Emax × [agonist] ÷ ([agonist] + EC50).
| Concentration | Agonist A | Agonist B |
|---|
| 10 nM | 50% | 5.5% |
| 30 nM | 75% | 13.8% |
| 90 nM | 90% | 28.4% |
| 100 nM | 90.9% | 30% |
Step 4: interpret. At 100 nM, agonist B gives 30% of the system maximum, which is half of its own Emax, exactly as the definition of EC50 says. Note that 90 nM is nine times the EC50 of A and gives 90% of its maximum, a useful check when sketching curves.
Where students lose marks: calling the drug with the bigger effect "more potent", reading EC50 as the concentration giving 50% of the system maximum instead of 50% of that drug's own maximum, and plotting concentration on a linear axis so the curve is not sigmoid. A partial agonist can also act as an antagonist in the presence of a full agonist, a common follow-up question.